Journal
JOURNAL OF CANCER
Volume 10, Issue 9, Pages 2025-2034Publisher
IVYSPRING INT PUBL
DOI: 10.7150/jca.29457
Keywords
Long non-coding RNA; UASR1; oncogenic lncRNA; AKT/mTOR; Breast cancer
Categories
Funding
- National Natural Science Foundation of China [81772842, 81802947]
Ask authors/readers for more resources
Long non-coding RNAs (lncRNAs) are non-coding RNAs longer than 200 nucleotides that function as regulatory factors in many human diseases, including cancer. However, majority of lncRNAs remain to be characterized. In this study, we characterized a novel lncRNA transcript, named UNC5B antisense RNAI (UASRI ). UASRI is 647bp in length consisting of two exons. This lncRNA is an antisense of intron 1 of unc-5 netrin receptor B (UNC5B) gene. In breast cancer tissues, UASRI was upregulated. Ectopic expression of UASRI promoted proliferation and clonogenic growth of breast cancer cells MCF7 and MDA-MB-231. The migration of these cells also increased as demonstrated by wound healing and transwel I assays. In contrast, silencing of UASRI suppressed cell proliferation and migration. Further studies showed that UASRI activated AKT and AKT-mediated mTOR signaling pathway to stimulate cell proliferation and growth. In these cells, active pAKT, pTSC2, p4EBP1 and pp70S6K were increased. Taken together, our data suggest that UASRI plays an oncogenic role in breast cancer cells through activation of the AKT/mTOR signaling pathway, being a novel RNA oncogene.
Authors
I am an author on this paper
Click your name to claim this paper and add it to your profile.
Reviews
Recommended
No Data Available